Chile and Brazil strengthen biotech and trade ties:
This article was originally published in Clinica
Executive Summary
Chile and Brazil have signed a series of bilateral accords in a range of areas including health technology and trade. Biotechnology and genomics are among the areas of common interest in medical research; the two countries plan to set up new projects in these areas. The Chilean and Brazilian presidents, Ricardo Lagos and Fernando Henrique Cardoso, met last week in Arica, northern Chile, to also sign commercial agreements that seek to improve the flow of trade between the two countries, such as by reducing import/export tariffs. Other technical co-operation agreements involve joint investments in Brazilian small and medium-sized companies, reports the state news agency Agencia Brasil.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.